The National Science Foundation (NSF) is an independent federal agency established in 1950 and based in Alexandria, Virginia. It is dedicated to supporting research and education in science and engineering across a wide range of disciplines. The NSF provides significant non-dilutive funding, up to $1.5 million, to startups and small businesses through its America's Seed Fund initiative, which is part of the Small Business Innovation Research (SBIR) program mandated by Congress. With an operating budget of approximately $7.8 billion, the NSF is committed to advancing fundamental research and education, thus fostering innovation and technological development in the United States.
SOSV is a global venture capital firm based in Princeton, New Jersey, founded in 1995. It specializes in early-stage investments, focusing on deep technology innovations that address human and planetary health. The firm operates startup development programs, notably HAX and IndieBio, which provide resources, facilities, and lab equipment to accelerate the growth of promising startups. SOSV supports companies from their inception through various funding stages, including seed and series A rounds, while offering ongoing assistance to help them scale and attract additional investors. By concentrating on revolutionary technologies and cross-border markets, particularly in Asia, SOSV aims to foster significant advancements that benefit humanity and the environment.
HAX is a venture capital program focused on accelerating hardware startups, operating from San Francisco and Shenzhen. Established in 2012, HAX provides founders with essential resources to rapidly prototype and iterate their products, encompassing physical models, technology developments, user interaction studies, and comprehensive business plans. The program supports accepted teams through a combination of full-time staff, mentors, and a vibrant startup community, emphasizing the development of scalable business strategies. Once products are ready for market introduction, teams transition to San Francisco, where HAX assists with business development, fundraising, and establishing critical partnerships. The program includes specialized initiatives such as HAX Growth, a 7-week bootcamp for launching B2C and B2B hardware startups, and HAX Boost, which helps teams refine their sales and marketing strategies while preparing for growth. HAX is part of SOSV, a global venture capital firm with a diverse portfolio, focusing on technology startups that aim to create meaningful innovations.
MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. Our mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator annually features 100 companies that address one or more of the transformative themes identified in an annual survey of leading manufacturers and providers.
Khosla Ventures, founded in 2004 and headquartered in Menlo Park, California, is a venture capital firm that provides strategic advice, capital, and support to bold entrepreneurs across various sectors. The firm focuses on early-stage investments in areas such as artificial intelligence, climate technology, sustainability, enterprise solutions, consumer products, fintech, digital health, medical technology, and therapeutics. Khosla Ventures is particularly interested in innovative solutions that address significant socio-economic challenges and enhance productivity, especially for low-income populations and small businesses in emerging markets. The firm embraces experimentation and is open to investing in unconventional and high-risk ventures, often acting as the sole investor in groundbreaking projects. With a commitment to fostering impactful entrepreneurship, Khosla Ventures seeks to create value through technological advancements and creative business models, with a special emphasis on markets in South Asia.
Clearway Pain Solutions Institute, LLC is a pain management medical center founded in 2013 and located in Pensacola, Florida. The institute focuses on relieving pain, restoring function, and enhancing the quality of life for patients through compassionate, patient-centered care. It offers a range of services, including interventional pain management, medication management, regenerative medicine, chiropractic care, massage therapy, and physical therapy. By employing a collaborative approach, Clearway Pain Solutions integrates the expertise of leading physicians, advanced practitioners, chiropractors, physical therapists, and dedicated support staff to empower patients to lead happier and healthier lives.
EMOTIV Inc. is a bioinformatics company based in San Francisco, California, focused on developing brain wearables that enhance the understanding of the human brain through electroencephalography (EEG). The company offers a range of products, including neuroheadsets and wireless EEG devices that record and translate brainwaves, along with software solutions designed to facilitate brain-computer interface applications. EMOTIV's technologies cater to various sectors such as gaming, healthcare, robotics, automotive, and market research. Recognized as a pioneer in its field, EMOTIV has received numerous international awards for its innovative designs and contributions to brain research. Founded in 2011, the company also boasts a global community of developers and researchers, furthering advancements in brain health and cognitive potential through the application of artificial intelligence and machine learning.
NeuroOne Medical Technologies Corporation is a medical technology company based in Eden Prairie, Minnesota. It is dedicated to the development and commercialization of advanced thin film electrode technology designed for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording. The company's focus extends to spinal cord stimulation, brain stimulation, and ablation solutions, targeting patients with conditions such as epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain resulting from failed back surgeries. NeuroOne aims to provide minimally invasive, high-definition solutions that enhance patient outcomes while potentially reducing procedural costs in the treatment of various neurological disorders.
Golden Falcon Capital is a venture capital firm established in 2021, located in Wilmington, Delaware. The firm specializes in providing investment services with a focus on technology sectors including software as a service (SaaS), infrastructure software, security, fintech, insurance technology, commerce, artificial intelligence, analytics, and consumer technology. Golden Falcon Capital targets technology companies in the United States, Israel, and emerging markets, aiming to support innovation and growth in these dynamic industries. The firm communicates with potential and current clients through phone and email.
Founded in 2009 by Marc Andreessen and Ben Horowitz, Andreessen Horowitz is a venture capital firm based in Menlo Park, California. The firm specializes in incubating and investing in startups across various stages, from seed to late-stage funding. It primarily focuses on sectors such as technology, including software, cloud computing, enterprise software, and consumer Internet. Additionally, it invests in emerging fields like artificial intelligence, fintech, and healthcare, specifically targeting companies at the intersection of technology and life sciences, such as digital therapeutics and computational medicine. Andreessen Horowitz is committed to fostering innovation and supporting companies that contribute to American dynamism, while strategically avoiding investments in areas like clean energy, transportation, and consumer retail.
Seven Seas Partners is a venture capital investment firm based in Menlo Park, California, established in 2014. The firm specializes in investing in early growth and growth-stage companies, primarily focusing on sectors such as consumer and mobile internet, software as a service (SaaS), the Internet of Things, and enterprise cloud infrastructure and services. Seven Seas Partners aims to support innovative enterprises in the United States and Mainland China, leveraging its expertise in high-technology to drive growth and development within these industries.
PsyMed Ventures is a venture capital firm based in San Francisco, California, specializing in early-stage investments in the psychedelics sector. Founded in 2020 by Matias Serebrinsky and Dina Burkitbayeva, the firm focuses on innovative areas such as psychedelic medicine, neurotechnology, human augmentation, precision psychiatry, and digital therapeutics. By targeting these emerging fields, PsyMed Ventures aims to support the development of groundbreaking solutions that can transform mental health treatment and enhance human well-being.
We make early investments in global healthcare technology companies that address prevention, disease management and health system efficiency that are relevant to emerging Asia We believe that innovation can happen anywhere, from the streets of Dhaka to the labs of Oxford, however without the right support network, these solutions might not scale, or find the best world-changing application. This is where we can help.
Enterprise Ireland is a government agency based in Dublin, Ireland, established in 1998 to foster the growth and development of indigenous businesses. Its primary mission is to assist Irish enterprises in achieving a strong presence in global markets, thereby enhancing national and regional prosperity. The agency supports a wide range of companies, from high-potential start-ups to established businesses, by providing funding, resources, and guidance. Additionally, Enterprise Ireland collaborates with college-based researchers to facilitate the development and commercialization of innovative technologies through licensing and spin-out companies. By focusing on innovation and export sales, Enterprise Ireland plays a crucial role in driving economic growth and competitiveness within the Irish economy.
Lumo Labs is a venture capital investment firm based in Eindhoven, Netherlands, with an additional office in Los Angeles. It operates as both a venture capital firm and a venture builder, focusing on early-stage companies from pre-seed to series A. Lumo Labs invests in ventures that leverage emerging technologies, including artificial intelligence, blockchain, IoT, and VR/AR, to address significant social challenges. The firm emphasizes sectors such as sustainable cities and communities, health and well-being, and quality education. By connecting innovative start-ups with capital, expertise, and a robust network, Lumo Labs aims to create impactful opportunities that drive technological advancement and social improvement.
Osaka University Venture Capital is a venture capital firm established in 2014, serving as the investment arm of Osaka University in Japan. The firm specializes in early-stage ventures and focuses on sectors such as healthcare, life science, artificial intelligence, machine learning, big data, and innovations in life and green technology. With a preference for minority seed and early-stage investments, Osaka University Venture Capital aims to support the development of innovative solutions within these fields, contributing to advancements that align with the university's mission of fostering research and entrepreneurship.
WI Harper Group is a venture capital firm established in 1993 and headquartered in San Francisco, California, with additional offices in Beijing and Taipei. The firm specializes in early to growth-stage investments across the United States, Greater China, and the Asia Pacific, focusing primarily on sectors such as technology, healthcare, biotechnology, artificial intelligence, robotics, fintech, sustainability, and new media. WI Harper Group has made over 300 investments and achieved more than 80 successful exits. With a dedicated team of 19 investment professionals, the firm manages nine funds and has over $1 billion in capital. Its notable investment track record includes companies like DivX, Focus Media, Vizio, SiRF, and Commerce One.
Techstart Ventures is a venture capital firm based in Belfast, Northern Ireland, founded in 2014. The firm specializes in early-stage investments, focusing primarily on the information technology sector. Techstart Ventures aims to support exceptional founders who are pursuing significant global opportunities, primarily targeting companies in Scotland and Northern Ireland. Through its investments, the firm seeks to foster innovation and growth within the technology landscape of these regions.
Crowdcube Limited is an equity crowdfunding platform based in Exeter, United Kingdom, with an additional office in London. Founded in 2009, the company allows entrepreneurs of start-ups and growing businesses to raise funds from a diverse network of investors, including friends, family, and the general public. Through Crowdcube, individuals can invest in small companies in exchange for equity or an annual return, thereby democratizing access to investment opportunities that were once primarily available to corporate investors. Since pioneering equity crowdfunding in 2011, Crowdcube has facilitated over £300 million in investments from more than 390,000 investors, supporting over 520 successful fundraising campaigns. Notable businesses that have utilized the platform include Monzo, River Cottage, and the Eden Project, among others.
UCB SA is a biopharmaceutical company headquartered in Brussels, Belgium, specializing in the development of therapies for neurology and immunology diseases. The company offers a range of products, including Cimzia for inflammatory conditions, Vimpat and Briviact for epilepsy, and Neupro for Parkinson's disease. Additionally, UCB produces Nayzilam, a nasal spray for seizure clusters, and Evenity for osteoporosis. Its pipeline includes promising treatments like padsevonil for drug-resistant epilepsy and rozanolixizumab for myasthenia gravis. UCB is also engaged in contract manufacturing and has established collaboration agreements with several pharmaceutical companies, including Sanofi and Amgen. Founded in 1928, UCB has a strong focus on research and development aimed at improving patient outcomes for individuals living with severe diseases, underlining its commitment to advancing medical science and patient care.
The National Institutes of Health (NIH) is a leading biomedical research facility in the United States, operating under the Department of Health and Human Services. Established in 1887 and based in Bethesda, Maryland, NIH is the primary agency responsible for biomedical and health-related research in the country. It comprises 27 separate institutes and centers, each focusing on different disciplines within biomedical science. NIH conducts its own scientific research through the Intramural Research Program and provides significant funding for research at external institutions via the Extramural Research Program. With a workforce that includes 1,200 principal investigators and over 4,000 postdoctoral fellows, NIH has been instrumental in major medical breakthroughs, such as the development of vaccines for hepatitis and human papillomavirus, as well as the discovery of treatments for various health conditions. As the world's largest source of medical research funding, NIH continues to advance scientific knowledge and contribute to public health improvements.
Clarendon Fund Managers Limited is a venture capital firm based in Belfast, Northern Ireland, that specializes in investing in small and medium enterprises across various sectors. Established in 2001, the firm focuses primarily on manufacturing and tradable services, preferring to support companies located in Northern Ireland. Clarendon typically invests between £20,000 and £250,000 in initial funding and is open to providing additional financing as needed. The firm has a strategic goal of exiting its investments within five to seven years. Clarendon manages regional venture capital funds, including a significant co-investment fund, and has a robust track record, having invested in over 60 companies since its inception.
Graham Partners is a private equity investment firm founded in 1988 and based in Newtown Square, Pennsylvania. The firm specializes in acquiring and investing in growth-oriented companies across various sectors, including industrial technology, software, medical devices and life sciences, consumer and food manufacturing, and advanced manufacturing. With a focus on the United States and Canada, Graham Partners leverages its expertise to support the development and expansion of its portfolio companies. The firm is also a Registered Investment Adviser, reflecting its commitment to professional standards in investment management.
MassChallenge is a global nonprofit startup accelerator headquartered in Boston, Massachusetts, founded in 2009. It supports early-stage entrepreneurs from various industries, including technology, healthcare, and finance, by providing mentorship, resources, and networking opportunities. With locations in countries such as Israel, Mexico, Switzerland, and Texas, MassChallenge operates a non-equity model, allowing startups to retain full ownership while benefiting from expert guidance and connections. The accelerator conducts various programs tailored to specific sectors, such as MassChallenge HealthTech and MassChallenge FinTech, which facilitate partnerships between startups and established enterprises to drive innovation and market growth. Through its extensive global network, MassChallenge aims to strengthen the innovation ecosystem and empower high-potential startups to create meaningful impact.
Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.
Elevate Capital is a venture capital firm founded in 2016 and based in Hillsboro, Oregon, with an additional office in Portland. The firm focuses on seed and early-stage investments, particularly in the Pacific Northwest, while also seeking opportunities globally. Elevate Capital specializes in technology and tech-enabled businesses, as well as sectors such as athletic apparel, outdoor products, and food and beverage. The firm is committed to supporting under-represented founders, maintaining a diverse portfolio with a 50/50 male-to-female founder ratio and ensuring that all investments include at least one co-founder from a minority group. Elevate Capital typically targets investments ranging from $0.03 million to $0.5 million, primarily making minority investments in its portfolio companies.
Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.
ah! Ventures is India’s only curated, sector agnostic and the largest fundraising platform for early stage startups raising funds up to 10 MN USD. Very strong network of 3000+ Investors including 2000+ angel investors and 1000+ institutional investors & fund/family houses, Robust deal pipeline of more than 600 business plans/month and Well-established brand as one of India’s premier aggregators with a cornucopia of offerings to catalyze startup growth.
eHealth Ventures is a consortium conceived to provide incubation services to promising early-stage healthcare technology companies in Israel. The Government of Israel offers a unique opportunity for leverage by providing significant financial incentives to incubators assisting technology start-ups capitalizing on Israel's extraordinarily rich talent pool. The next Tender is expected the second half of 2014. eHealth Ventures will apply for an eight-year license under the program. They are seeking qualified individual and institutional investors who would like to participate in this extraordinary, highly leveraged opportunity.
Thiel Capital is an investment firm founded by Peter Thiel, situated in the Presidio of San Francisco. The firm specializes in investments across diverse sectors, including artificial intelligence, drones, and healthcare. Thiel Capital is dedicated to providing strategic and operational support for Thiel's various investment initiatives and entrepreneurial projects. The firm is associated with several related organizations, such as Clarium, Founders Fund, Mithril, Valar Ventures, and The Thiel Foundation, which reflect its broad engagement in fostering innovation and entrepreneurship.
Furthr VC, founded in 1990 and based in Dublin, Ireland, is a venture capital firm focused on early-stage investments in ambitious software and medtech companies. The firm targets Seed to Series A funding rounds, forming close partnerships with founders to support their growth. Furthr VC takes a hands-on approach, assisting teams in key strategic areas to accelerate their development. In addition to providing initial capital, the firm allocates significant resources for follow-on investments in subsequent funding rounds, ensuring that it remains engaged throughout the founders' journey.
Atlantic Bridge is a growth equity firm based in Dublin, Ireland, founded in 2004. The company focuses on investing in deep technology sectors, including cybersecurity, cloud computing, artificial intelligence, machine learning, and health technology, among others, in both Europe and the United States. Atlantic Bridge's team comprises experienced entrepreneurs, technology executives, and investment professionals with extensive international business experience. The firm employs a distinctive cross-border strategy that supports ambitious entrepreneurs and management teams in scaling their businesses and capitalizing on significant growth opportunities. With offices in key locations such as London, Munich, Paris, and Palo Alto, Atlantic Bridge leverages its global platform to facilitate the international expansion of its portfolio companies. The firm's unique "Bridge Model" is designed to accelerate the growth of technology companies, demonstrating a commitment to delivering strong performance results while fostering a partnership approach in its investments.
The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.
Jolt Capital SAS is a private equity firm based in Paris, France, specializing in growth investments in mid-sized European technology companies. Founded in 2011, the firm focuses on businesses with revenues between €10 million and €100 million and a maximum EBITDA of €40 million. Jolt Capital targets various sectors, including information technology, telecommunications, cybersecurity, clean technology, artificial intelligence, health technology, and robotics. The firm provides financing for working capital, capital expenditures, and growth strategies, while also enhancing balance sheets and operational efficiencies. Jolt Capital typically invests between €5 million and €40 million, acquiring equity positions that may include board seats or minority stakes. By addressing the financial constraints that often hinder the growth of these companies, Jolt Capital plays a vital role in fostering their expansion and profitability within competitive markets.
EASME is a European Union executive agency that supports small and medium-sized enterprises and promotes innovation in Europe. It manages projects in the areas of small and medium-sized enterprises, as well as the environment, energy, and maritime sectors, funded by COSME, LIFE, and EMFF. EASME organizes the European Sustainable Energy Week and serves industries such as environmental management, energy production, and maritime activities.
Utrecht Health Seed Fund is a venture capital firm established in 2020 and located in Utrecht, Netherlands. It is a collaborative initiative between Utrecht Holdings and the Economic Board Utrecht. The firm focuses on investing in start-ups and seed-stage companies within the life sciences sectors, including biotechnology, pharmaceuticals, diagnostics, as well as digital health, medical devices, and animal health. Utrecht Health Seed Fund typically invests between €100,000 and €250,000, primarily through convertible loans or equity, and prefers to engage in partnerships with co-investors to enhance its investment strategy.
The Alzheimer’s Drug Discovery Foundation (ADDF) is the only public charity solely dedicated to finding effective drugs for Alzheimer’s disease. Our pioneering biomedical venture philanthropy approach allows us to invest in the most promising drug discovery and development programs around the world in both academic institutions and biopharmaceutical companies. Since our founding in 1998, the ADDF has invested nearly $100 million to support over 500 programs across 18 countries.
Sunstone Management, Inc. is a venture capital and private equity firm founded in 2015, based in Irvine, California. The firm specializes in growth capital and focuses on small and lower middle market investments, primarily in the technology and services sectors. Sunstone Management is dedicated to providing comprehensive wealth management solutions for high net worth clients worldwide. The firm invests in early-stage technology companies and typically targets U.S.-based investments, offering a range of investment strategies that include short-term senior debt, equity, and venture capital options to meet the diverse goals of its investors.
Par Equity is a venture capital firm established in 2008 and headquartered in Edinburgh, United Kingdom. The firm focuses on investing in early-stage technology companies that demonstrate high growth potential, primarily within the regions of Northern England, Northern Ireland, and Scotland. Par Equity aims to support innovative businesses that contribute to the advancement of the technology sector in the North of the UK.
Bullnet Gestión, SGECR, S.A. is a venture capital firm established in 2001 and headquartered in Pozuelo de Alarcón, Spain. The firm specializes in early-stage to development capital financing, focusing on technology-oriented projects, particularly in software, hardware, and high-value added services. Bullnet typically invests between €1 million and €2.5 million in its portfolio companies, while remaining open to evaluating both smaller and larger investment opportunities. The firm aims to support companies that originate and are based in Spain and often co-invests in larger projects to enhance its portfolio.
US Army is a government agency that helps the army with day-to-day operations by providing specialized skills in a specific subject. The Army's goal is to fight and win our country's battles by delivering timely, persistent land dominance across the entire spectrum of military operations and conflicts in support of combatant commanders. Executing Title 10 and Title 32 United States Code commands entails organizing, equipping, and training forces to perform rapid and sustained combat operations on land. Completing missions designated by the President, Secretary of Defense, and combatant commanders, Transforming for the Future
Joyance Partners, LLC is a venture capital firm based in the United States that focuses on investing in early-stage startups. The firm is dedicated to identifying and supporting emerging science and bio-based technologies that enhance individual health and well-being. Its investment strategy emphasizes companies that aim to increase joy, fulfillment, and independence for their customers. Joyance Partners seeks to invest in the health and consumer sectors, targeting ventures that demonstrate potential for impactful innovation within a two-year timeframe. The firm's mission is to cultivate joy and improve quality of life through scientific advancements and technology.
Venture Kick, a private philanthropic initiative, provides as much 150,000 Swiss francs in pre-seed funding to Swiss startups and offers structured, entrepreneurial training to build robust, winning businesses. Entrepreneurs pitch for finance as many as three times, as they compete for increasing amounts of funding at each stage. Founders gain direct feedback from the expert juries and access to an international network of successful entrepreneurs and investors. Venture Kick has supported 600 Swiss startup projects with 24.9 million francs to date. Supported projects have incorporated as 454 active companies, creating 6,033 jobs, and attracting 2.49 billion francs worth of subsequent investment. Companies founded by Venture Kick alums represented 55 percent of the TOP 100 Swiss Startup Award 2018. In 2019 Venture Kick will support idea-stage startup projects with 4.35 million francs, to bring Swiss science to global markets.
SIG's China venture capital and private equity activities are operated through SIG Asia Investments, LLLP (SAI) and its wholly foreign owned enterprise (WFOE) based in Shanghai with a branch office in Beijing. The SIG China team seeks to commit the firm’s capital to venture capital and private equity investments in China. SAI is a member of the Susquehanna International Group of companies (SIG), which has evolved over the past 20+years into a leading financial institution focusing on trading and market making, institutional sales and research, private equity, and venture capital. With more than 1,400 employees across offices worldwide, SIG’s professionals develop ideas in an entrepreneurial environment, taking full advantage of SIG’s cutting edge technology and quantitative research. SIG is committed to expanding its global businesses in China. As part of that effort SAI has been mandated to commit SIG's proprietary capital in VC and PE investments in companies operating in the PRC.
Artesian VC is an alternative investment management company that specializes in early-stage venture capital, particularly in the clean energy sector. Established in 2004 after spinning out from ANZ Banking Group, the company has evolved to manage a range of specialized funds, with a focus on seed and follow-on investments in startups sourced from approved accelerators, incubators, and academic programs. Artesian's investment strategy emphasizes partnerships with leading organizations in the startup ecosystem, enabling it to identify and support high-potential ventures. With offices in Sydney, Melbourne, Shanghai, New York, London, and Singapore, the company has built a global presence and has successfully raised over AUD 255 million for its various funds. Additionally, Artesian has expanded its reach through initiatives like its China VC Fund and plans for a Southeast Asia VC Fund, underscoring its commitment to fostering innovation in diverse markets.
Investissement Québec is a Canadian financial institution established in 1998, dedicated to supporting the growth of small and medium-sized enterprises (SMEs) as well as large companies in the province of Québec. The organization offers a variety of financing solutions and consulting services to assist businesses in their expansion projects. By combining the strengths of financial institutions and economic development agencies, Investissement Québec aims to facilitate the establishment and growth of companies within the region. The institution plays a crucial role in providing financial assistance and guidance to corporations looking to invest in Québec, thereby contributing to the local economy.
Desjardins Capital is a private equity and venture capital firm based in Québec, Canada, and is a part of the Mouvement des caisses Desjardins. The firm specializes in investing in a variety of sectors, including healthcare, industrial technology, food, retail, and manufacturing. Its investment focus includes startups and companies at various growth stages, providing both equity and debt financing. Desjardins Capital targets businesses with significant growth potential, particularly those with proprietary intellectual property and a strong presence in Québec. The firm typically invests between $0.09 million and $24.22 million in equity, as well as offering loans ranging from $0.09 million to $484 million. In addition to traditional investments, it supports cooperatives and worker shareholder cooperatives, emphasizing sustainable growth and community development. Desjardins Capital has a history of fostering regional economic prosperity and aims to make a positive impact on the communities it serves.
ShangBay Capital is a venture capital firm established in 2015 and located in Palo Alto, California. The firm specializes in investing in the life sciences sector, with a particular focus on medical devices, biotechnology, and mobile healthcare companies within the United States. As a Registered Investment Adviser, ShangBay Capital seeks to support innovative early-stage companies that are poised to make significant advancements in healthcare technology.
ACF Investors, established in 2011 and based in Sheffield, United Kingdom, operates as a venture capital entity that collaborates with experienced angel investors to support early-stage businesses. The firm focuses on co-investing alongside syndicates of angel investors, leveraging their sector-specific expertise to identify and fund high-potential companies. ACF Investors has built a strong portfolio, having invested over £40 million in partnership with more than £200 million from angel investors and other sources, resulting in a diverse collection of over 80 companies. The organization is dedicated to fostering the growth of small and medium-sized enterprises throughout the UK, often providing support through multiple funding rounds as these companies scale.